Extended thrombotic prophylaxis in COVID-19 early discharge: A retrospective cohort study
PLOS One · 2026
DOI: 10.1371/journal.pone.0340889 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, 2026. Verfasst von Sebastiaan T Van't Hoff und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Amphia Hospital, Breda, the Netherlands. Hauptthemen laut MEDLINE: COVID-19, Nadroparin, Anticoagulants, Venous Thrombosis. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction/Background Due to limits in available staff and space during the COVID-19 pandemic, home monitoring programmes were introduced, reducing strain on resources, and preventing readmissions. Several hospitals included prophylaxis for venous thrombotic events (VTE), as COVID-19 appeared to be thrombogenic. Other hospitals did not, expecting patients to be more mobile while at home. Our aim was to determine whether the administration of nadroparin has led to a difference in VTE occurrence between two groups of previously included patients. Materials and methods Retrospective cohort study of two cohorts included in home monitoring with the same protocol, except for nadroparin prophylaxis.
Results
663 patients were analysed in equal groups from two hospitals. No significant difference was found in occurrence of VTE after discharge, readmissions in general or readmissions due to VTE in otherwise comparable groups.
Discussion
As opposed to trials determining thrombotic prophylaxis was of benefit after discharge due to COVID-19, we found no difference between our groups. Our study was retrospective and comprised data compiled over almost two years, which provides a relatively large sample size and overview through different treatment regimes.
Conclusion
For the future, thrombotic prophylaxis for COVID-19 home monitoring might not be indicated and reconsidered for different home monitoring programmes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Amphia Hospital, Breda, the Netherlands.
- Department of Pulmonary Diseases, Maasstad Hospital, Rotterdam, the Netherlands.
- Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands.
ORCID-Profile: Sebastiaan T Van't Hoff
Zitieren
APA
Van't Hoff, S. T., Helfrich, G., Boerman, S., & Hardeman, H. A. (2026). Extended thrombotic prophylaxis in COVID-19 early discharge: A retrospective cohort study. PLOS One. https://doi.org/10.1371/journal.pone.0340889
Vancouver
Van't Hoff ST, Helfrich G, Boerman S, Hardeman HA. Extended thrombotic prophylaxis in COVID-19 early discharge: A retrospective cohort study. PLOS One. 2026. doi:10.1371/journal.pone.0340889
BibTeX
@article{VantHoff2026,
author = {Van't Hoff, Sebastiaan T and Helfrich, Gea and Boerman, Sanne and Hardeman, Hans A},
title = {Extended thrombotic prophylaxis in COVID-19 early discharge: A retrospective cohort study},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0340889}
}
EUVIMED